Paul Gregor

Directeur Général chez Rimonyx Pharmaceuticals Ltd.

Health Technology

Consumer Services

Government

Postes actifs de Paul Gregor

Sociétés	Poste	Début	Fin
Rimonyx Pharmaceuticals Ltd. Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel	Directeur Général	01/01/2002	-
	Fondateur	25/11/2009	-

Sociétés	Poste	Début	Fin
W WORL	Directeur Technique/Scientifique/R&D	-	-
Bayer Pharmaceuticals Corp.	Corporate Officer/Principal	-	-
National Institutes of Health National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	-	-
The Salk Institute for Biological Studies	Corporate Officer/Principal	-	-
National Institute on Drug Abuse	Corporate Officer/Principal	-	-

Weizmann Institute of Science

Undergraduate Degree

Internationale

Etats-Unis	6
Israël	3

Opérationnelle

Corporate Officer/Principal	4
Chief Executive Officer	1
Founder	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
W WORL	Health Technology

Entreprise privées	4
Bayer Pharmaceuticals Corp.
National Institutes of Health National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.	Government
National Institute on Drug Abuse	Government
Rimonyx Pharmaceuticals Ltd. Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel	Health Technology